Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity

Clinical and Experimental Immunology

Volumn 139, Issue 3, 2005, Pages 569-574

  Yu, F ^a   Zhao, Ming Hui ^a   Zhang, Y K ^a   Zhang, Y ^a   Wang, H Y ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Anti endothelial cell antibodies (AECA); Antineutrophil cytoplasmic antibodies (ANCA); Propylthiouracil (PTU); Vasculitis

Indexed keywords

ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ENDOTHELIAL CELL ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROPYLTHIOURACIL;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULITIS;

ADOLESCENT; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL CULTURE TECHNIQUES; CHI-SQUARE DISTRIBUTION; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPYLTHIOURACIL; VASCULITIS;

EID: 14744298635     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02725.x     Document Type: Article

References (47)

1. Dolman KM, Gans RO, Vervaat TJ et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342:651-2.
2. Xu XD, Zhao MH, Zhang YK, Guo XH, Wang HY. Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibody-positive vasculitis and their target antigens: a report of 4 cases and literature review. Zhonghua Nei Ke Za Zhi 2002; 41:404-7.
3. Choi HK, Merkel P, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 2000; 43:405-13.
4. Sato H, Hattori M, Fujieda M et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J Clin Endocrinol Metab 2000; 85:4270-3.
5. Yamauchi K, Sata M, Machiya J et al. Antineutrophil cytoplasmic antibody positive alveolar haemorrhage during propylthiouracil therapy for hyperthyroidism. Respirology 2003; 8:532-5.
6. Jacobs EM, Hartkamp A, Kaasjager HA. PTU-associated cutaneous vasculitis with ANCA anti-MPO and anti-PR3 antibodies. Neth J Med 2003; 61:296-9.
7. Guo XH, Zhao MH, Gao Y, Wang SF, Gao Y. Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents. Nat Med J China 2003; 83:932-5.
8. Gao Y, Zhao MH, Guo X-H, Xin G, Gao Y, Wang H-Y. Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis induced by antithyroid agents. Endocrinol Res 2004; 30:205-13.
9. Cid MC, Segarra M, Garcia-Martinez A, Hernandez-Rodriguez J. Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis. Curr Rheumatol Rep 2004; 6:184-94.
10. Healy CM, Carvalho D, Pearson JD, Thornhill MH. Raised antiendothelial cell autoantibodies (AECA), but not anti-neutrophil cytoplasmic autoantibodies (ANCA), in recurrent oral ulceration, modulation of AECA binding by tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma). Clin Exp Immunol 1996; 106:523-8.
11. Fujieda M, Oishi N, Kurashige T. Antibodies to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment. Clin Exp Immunol 1997; 107:120-6.
12. Triolo G, Triolo G, Accardo-Palumbo A et al. IgG anti-endothelial cell antibodies (AECA) in type I diabetes mellitus; induction of adhesion molecule expression in cultured endothelial cells. Clin Exp Immunol 1998; 111:491-6.
13. D'Cruz DP, Keser G, Direskeneli H, Khamashta MA, Hughes GR. Anti-endothelial cell antibodies in systemic vasculitis and systemic lupus erythematosus (SLE): effects of heat inactivation on binding and specificity. Clin Exp Immunol 1999; 115:567-70.
14. Ihn H, Sato S, Fujimoto M et al. Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol 2000; 119:203-9.
15. Bordron A, Revelen R, D'Arbonneau F et al. Functional heterogeneity of anti-endothelial cell antibodies. Clin Exp Immunol 2001; 124:492-501.
16. Grunebaum E, Blank M, Cohen S et al. The role of anti-endothelial cell antibodies in Kawasaki disease in vitro and in vivo studies. Clin Exp Immunol 2002; 130:233-40.
17. Yang YH, Wang SJ, Chuang YH, Lin YT, Chiang BL. The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-alpha treatment in children with Henoch-Schonlein purpura. Clin Exp Immunol 2002; 130:352-7.
18. Tripathy NK, Sinha N, Nityanand S. Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity. Clin Exp Immunol 2003; 134:360-4.
19. Weissman AM. Solubilization of cellular proteins. In: John E, Coligan ADA, Kruisbeek M et al., eds. Current protocols in immunology. London: Greene Publishing Associated and Wiley-Interscience, 1991:8.1.1-8.1.9.
20. Wood NL, Schook LB, Studer EJ et al. Biochemical characterization of human vascular endothelial cell monocyte antigens defined by monoclonal antibodies. Transplantation 1988; 45:787-92.
21. Lee KH, Chung HS, Kim HS et al. Human alpha-enolase from endothelial cell as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis Rheum 2003; 48:2025-35.
22. Revelen R, D'Arbonneau F, Guillevin L, Bordron A, Youinou P, Dueymes M. Comparison of cell-ELISA, flow cytometry and Western blotting for the detection of antiendothelial cell antibodies. Clin Exp Rheumatol 2002; 20:19-26.
23. Wada N, Mukai M, Kohno M, Notoya A, Ito T, Yoshioka N. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole. Endocrinol J 2002; 49:329-34.
24. Noh JY, Asari T, Hamada N et al. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol (Oxf) 2001; 54:651-4.
25. Haubitz M, Gerlach M, Kruse HJ, Brunkhorst R. Endothelial tissue factor stimulation by proteinase 3 and elastase. Clin Exp Immunol 2001; 126:584-8.
26. Weidebach W, Viana VS, Leon EP et al. C-ANCA-positive IgG fraction from patients with Wegener's granulomatosis induces lung vasculitis in rats. Clin Exp Immunol 2002; 129:54-60.
27. Holland M, Takada K, Okumoto T et al. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Clin Exp Immunol 2002; 129:183-90.
28. van der Geld YM, Tool AT, Videler J et al. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis. Clin Exp Immunol 2002; 129:562-70.
29. Ohlsson S, Wieslander J, Segelmark M. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies- associated systemic vasculitis in remission. Clin Exp Immunol 2003; 131:528-35.
30. Clayton AR, Savage CO. Production of antineutrophil cytoplasm antibodies derived from circulating B cells in patients with systemic vasculitis. Clin Exp Immunol 2003; 132:174-9.
31. Patry YC, Nachman PH, Audrain MA, Falk RJ, Meflah K, Esnault VL. Difference in antigenic determinant profiles between human and rat myeloperoxidase. Clin Exp Immunol 2003; 132:505-8.
32. Day CJ, Hewins P, Savage CO. New developments in the pathogenesis of ANCA-associated vasculitis. Clin Exp Rheumatol 2003; 21 (Suppl. 6):S35-48.
33. Selga D, Segelmark M, Wieslander J, Gunnarsson L, Hellmark T. Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins. Clin Exp Immunol 2004; 135:164-72.
34. Schreiber A, Luft FC, Kettritz R. Membrane proteinase 3 expression and ANCA-induced neutrophil activation. Kidney Int 2004; 65:2172-83.
35. Heeringa P, Cohen Tervaert JW. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? Kidney Int 2004; 65:1564-7.
36. Hewins P, Williams JM, Wakelam MJ, Savage CO. Activation of Syk in neutrophils by antineutrophil cytoplasm antibodies occurs via Fcgamma receptors and CD18. J Am Soc Nephrol 2004; 15:796-808.
37. Reumaux D, Duthilleul P, Roos D. Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies. Hum Immunol 2004; 65:1-12.
38. Ye H, Zhao MH, Gao Y et al. Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule. Clin Exp Immunol 2004; 138:179-82.
39. Del Papa N, Conforti G, Gambini D et al. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 1994; 70:211-6.
40. Yu F, Zhao MH, Zhang YK, Zhang Y, Wang HY. The significance of anti-endothelial cell antibodies in patients with ANCA associated systemic vasculitis and their target antigens. Chin J Nephrol 2004; 20(Suppl.):11-5.
41. Gobel U, Eichhorn BG, Kettritz R et al. Disease activity and autoantibodies to endothelial cell in patients with Wegener's granulomatosis. Am J Kidney Dis 1996; 28:186-94.
42. Del Papa N, Guidali L, Sironi M et al. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 1996; 39:758-66.
43. Savage COS, Pottinger BE. Vascular damage in Wegener's granulomatosis and microscopic polyarteritis presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 1991; 85:14-19.
44. Meyer O, Kaiser P, Haim T et al. Anti-vascular endothelial cell antibodies (AECA): comparison of two assay methods and clinical applications. Rev Rhum Engl Ed 1995; 62:737-47.
45. Del Papa N, Meroni PL, Barcellini W et al. Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clin Immunol Immunopathol 1992; 63:267-74.
46. Blank M, Krause I, Goldkorn T et al. Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels. Arthritis Rheum 1999; 42:1421-32.
47. Hellmich B, Csernok E, Trabandt A, Gross WL, Ernst M. Effect of G-CSF and GM-CSF on surface expression of MPO and PR3 on PMN in vitro. Clin Exp Immunol 2000; 120 (Suppl. 1):1-79.